These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34664836)

  • 21. Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study.
    Montes de Oca M; Lopez Varela MV; Jardim J; Stirvulov R; Surmont F
    Pulm Pharmacol Ther; 2016 Jun; 38():10-6. PubMed ID: 27113029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with misdiagnosis of COPD in primary care.
    Walters JA; Walters EH; Nelson M; Robinson A; Scott J; Turner P; Wood-Baker R
    Prim Care Respir J; 2011 Dec; 20(4):396-402. PubMed ID: 21687918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utility of normality low limit of spirometry in diagnosed COPD patients].
    Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
    Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV infection is an independent risk factor for decreased 6-minute walk test distance.
    Robertson TE; Nouraie M; Qin S; Crothers KA; Kessinger CJ; McMahon D; Chandra D; Kingsley LA; Greenblatt RM; Huang L; Fitzpatrick ME; Morris A
    PLoS One; 2019; 14(4):e0212975. PubMed ID: 31017909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).
    Yu WC; Fu SN; Tai EL; Yeung YC; Kwong KC; Chang Y; Tam CM; Yiu YK
    Int J Chron Obstruct Pulmon Dis; 2013; 8():389-95. PubMed ID: 24009418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
    Singh MP
    Int J Chron Obstruct Pulmon Dis; 2013; 8():613-9. PubMed ID: 24353411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory Conditions Update: Chronic Obstructive Pulmonary Disease.
    Karel DJ
    FP Essent; 2016 Sep; 448():20-8. PubMed ID: 27576232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
    Bhatt NY; Wood KL
    Drugs Aging; 2008; 25(9):717-28. PubMed ID: 18729545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Park HJ; Byun MK; Rhee CK; Kim K; Kim HJ; Yoo KH
    Respir Res; 2018 Sep; 19(1):185. PubMed ID: 30249256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study.
    Bourbeau J; Sebaldt RJ; Day A; Bouchard J; Kaplan A; Hernandez P; Rouleau M; Petrie A; Foster G; Thabane L; Haddon J; Scalera A
    Can Respir J; 2008; 15(1):13-9. PubMed ID: 18292848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and integrated management of COPD.
    Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.